Allspring Global Investments
VIVO

Allspring Global Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Allspring Global Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,084
Closed -$97K – 2970
2022
Q3 		$97K Sell
3,084
-4,576
-60% -$148K ﹤0.01% 2100
2022
Q2 		$233K Sell
7,660
-44,966
-85% -$1.22M ﹤0.01% 1770
2022
Q1 		$1.37M Buy
52,626
+143
+0.3% +$3.4K ﹤0.01% 1711
2021
Q4 		$1.07M Buy
+52,483
New +$1.01M ﹤0.01% 1903

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's VIVO Position: Q4 2022 in Review

Allspring Global Investments sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 3,084 shares — an estimated $97K sold.

Allspring Global Investments first reported a position in VIVO in Q4 2021 and held it in 4 quarters. The position peaked at $1.37M in Q1 2022. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Allspring Global Investments reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 3,084 Meridian Bioscience Inc shares in Q4 2022, an estimated $97K.
  • Allspring Global Investments first reported a position in Meridian Bioscience Inc in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Meridian Bioscience Inc position peaked at $1.37M in Q1 2022.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.